Role of Crizotinib in previously treated non-small-cell lung cancer

被引:3
作者
Gupta, Sunil Kumar [1 ]
机构
[1] Rajiv Gandhi Canc Inst & Res Ctr, Dept Med Oncol, Head & Neck Med Serv, Sect 5, New Delhi, India
关键词
D O I
10.4103/2278-330X.130468
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
[No abstract available]
引用
收藏
页码:138 / 140
页数:3
相关论文
共 10 条
[1]
Crizotinib for ALK-Rearranged Non-Small Cell Lung Cancer: A New Targeted Therapy for a New Target [J].
Gandhi, Leena ;
Jaenne, Pasi A. .
CLINICAL CANCER RESEARCH, 2012, 18 (14) :3737-3742
[2]
The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer [J].
Konopa, Krzysztof ;
Jassem, Jacek .
CURRENT DRUG TARGETS, 2010, 11 (01) :2-11
[3]
Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR. [J].
Maemondo, Makoto ;
Inoue, Akira ;
Kobayashi, Kunihiko ;
Sugawara, Shunichi ;
Oizumi, Satoshi ;
Isobe, Hiroshi ;
Gemma, Akihiko ;
Harada, Masao ;
Yoshizawa, Hirohisa ;
Kinoshita, Ichiro ;
Fujita, Yuka ;
Okinaga, Shoji ;
Hirano, Haruto ;
Yoshimori, Kozo ;
Harada, Toshiyuki ;
Ogura, Takashi ;
Ando, Masahiro ;
Miyazawa, Hitoshi ;
Tanaka, Tomoaki ;
Saijo, Yasuo ;
Hagiwara, Koichi ;
Morita, Satoshi ;
Nukiwa, Toshihiro .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (25) :2380-2388
[4]
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial [J].
Mitsudomi, Tetsuya ;
Morita, Satoshi ;
Yatabe, Yasushi ;
Negoro, Shunichi ;
Okamoto, Isamu ;
Tsurutani, Junji ;
Seto, Takashi ;
Satouchi, Miyako ;
Tada, Hirohito ;
Hirashima, Tomonori ;
Asami, Kazuhiro ;
Katakami, Nobuyuki ;
Takada, Minoru ;
Yoshioka, Hiroshige ;
Shibata, Kazuhiko ;
Kudoh, Shinzoh ;
Shimizu, Eiji ;
Saito, Hiroshi ;
Toyooka, Shinichi ;
Nakagawa, Kazuhiko ;
Fukuoka, Masahiro .
LANCET ONCOLOGY, 2010, 11 (02) :121-128
[5]
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma. [J].
Mok, Tony S. ;
Wu, Yi-Long ;
Thongprasert, Sumitra ;
Yang, Chih-Hsin ;
Chu, Da-Tong ;
Saijo, Nagahiro ;
Sunpaweravong, Patrapim ;
Han, Baohui ;
Margono, Benjamin ;
Ichinose, Yukito ;
Nishiwaki, Yutaka ;
Ohe, Yuichiro ;
Yang, Jin-Ji ;
Chewaskulyong, Busyamas ;
Jiang, Haiyi ;
Duffield, Emma L. ;
Watkins, Claire L. ;
Armour, Alison A. ;
Fukuoka, Masahiro .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (10) :947-957
[6]
Personalized medicine: Lung Cancer leads the way [J].
Parikh, P. ;
Puri, T. .
INDIAN JOURNAL OF CANCER, 2013, 50 (02) :77-79
[7]
Reade CA, 2009, BIOL-TARGETS THER, V3, P215
[8]
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer [J].
Scagliotti, Giorgio Vittorio ;
Parikh, Purvish ;
von Pawel, Joachim ;
Biesma, Bonne ;
Vansteenkiste, Johan ;
Manegold, Christian ;
Serwatowski, Piotr ;
Gatzemeier, Ulrich ;
Digumarti, Raghunadharao ;
Zukin, Mauro ;
Lee, Jin S. ;
Mellemgaard, Anders ;
Park, Keunchil ;
Patil, Shehkar ;
Rolski, Janusz ;
Goksel, Tuncay ;
de Marinis, Filippo ;
Simms, Lorinda ;
Sugarman, Katherine P. ;
Gandara, David .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) :3543-3551
[9]
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer [J].
Shaw, Alice T. ;
Kim, Dong-Wan ;
Nakagawa, Kazuhiko ;
Seto, Takashi ;
Crino, Lucio ;
Ahn, Myung-Ju ;
De Pas, Tommaso ;
Besse, Benjamin ;
Solomon, Benjamin J. ;
Blackhall, Fiona ;
Wu, Yi-Long ;
Thomas, Michael ;
O'Byrne, Kenneth J. ;
Moro-Sibilot, Denis ;
Camidge, D. Ross ;
Mok, Tony ;
Hirsh, Vera ;
Riely, Gregory J. ;
Iyer, Shrividya ;
Tassell, Vanessa ;
Polli, Anna ;
Wilner, Keith D. ;
Jaenne, Pasi A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (25) :2385-2394
[10]
ALK in Lung Cancer: Past, Present, and Future [J].
Shaw, Alice T. ;
Engelman, Jeffrey A. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (08) :1105-1111